-
EP2414376
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2414376
| EP2414376 - PHARMACEUTICAL COMPOSITION COMPRISING A STEROIDAL[3,2-C]PYRAZOLE DERIVATIVE AND A SECOND PHARMACEUTICALLY ACTIVE COMPOUND [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 14.02.2014 Database last updated on 30.10.2024 | Most recent event Tooltip | 14.02.2014 | Application deemed to be withdrawn | published on 19.03.2014 [2014/12] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2012/06] | Inventor(s) | 01 /
BURKAMP, Frank c/o AstraZeneca Intellectual Property AstraZeneca R&D Södertälje S-151 85 Södertälje / SE | 02 /
HANSEN, Peter AstraZeneca R&D Mölndal SE-431 83 Mölndal / SE | [2012/06] | Representative(s) | (deleted) | [2012/06] | Application number, filing date | 10759126.5 | 31.03.2010 | WO2010SE50356 | Priority number, date | US20090166310P | 03.04.2009 Original published format: US 166310 P | [2012/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010114472 | Date: | 07.10.2010 | Language: | EN | [2010/40] | Type: | A1 Application with search report | No.: | EP2414376 | Date: | 08.02.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.10.2010 takes the place of the publication of the European patent application. | [2012/06] | Search report(s) | International search report - published on: | SE | 07.10.2010 | Classification | IPC: | C07J71/00, A61K31/58, A61P11/00, A61P11/06, A61P29/00 | [2012/06] | CPC: |
A61K45/06 (EP,US);
A61K31/58 (EP,KR,US);
A61K9/0075 (EP,US);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/06 (EP);
A61P11/08 (EP);
A61P29/00 (EP);
A61P43/00 (EP);
C07J71/00 (KR)
(-)
| C-Set: |
A61K31/58, A61K2300/00 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/06] | Title | German: | PHARMAZEUTISCHE VERBINDUNG MIT EINEM STEROIDALEN [3,2-C]PYRAZOLDERIVAT UND EINEM ZWEITEN PHARMAZEUTISCHEN WIRKSTOFF | [2012/06] | English: | PHARMACEUTICAL COMPOSITION COMPRISING A STEROIDAL[3,2-C]PYRAZOLE DERIVATIVE AND A SECOND PHARMACEUTICALLY ACTIVE COMPOUND | [2012/06] | French: | COMPOSITION PHARMACEUTIQUE COMPRENANT UN DÉRIVÉ [3, 2-C]PYRAZOLE STÉROÏDE ET UN SECOND COMPOSÉ PHARMACEUTIQUEMENT ACTIF | [2012/06] | Entry into regional phase | 03.11.2011 | National basic fee paid | 03.11.2011 | Search fee paid | 03.11.2011 | Designation fee(s) paid | 21.10.2011 | Examination fee paid | Examination procedure | 21.10.2011 | Examination requested [2012/06] | 01.10.2013 | Application deemed to be withdrawn, date of legal effect [2014/12] | 31.10.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2014/12] | Fees paid | Renewal fee | 31.03.2012 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.03.2013 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XP]WO2009044200 (ASTRAZENECA AB [SE], et al); | [A]WO02088167 (GLAXO GROUP LTD [GB], et al); | [A]US3364203 (BEARD COLIN C, et al) |